Literature DB >> 23670187

Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Antal Rot1,2, Clive McKimmie3, Claire L Burt3, Kenneth J Pallas3, Thomas Jamieson4, Monika Pruenster1, Richard Horuk5, Robert J B Nibbs3, Gerard J Graham3.   

Abstract

Chemokines, acting on their cognate receptors on infiltrating leukocytes, drive the inflammatory response. We have been interested in determining roles and potential mechanisms for the atypical chemokine-scavenging receptor D6 in the regulation of inflammation. In this study, we show that a psoriasis-like pathology that arises in inflamed skins of D6-deficient mice is characterized by a massive and aberrant localization of neutrophils to the dermal/epidermal junction, which is associated with development of the pathology. Such misplacement of neutrophils is also seen with D6-deficient mice in other inflammatory models, suggesting a role for D6 in the spatial positioning of neutrophils within inflamed sites. We further show that D6 functions cell autonomously in this context and that D6, expressed by neutrophils, limits their migrational responses to CCR1 ligands such as CCL3. Our data therefore indicate that D6 is able to play a cell-autonomous role as a migratory rheostat restricting migration of D6-expressing cells such as neutrophils toward ligands for coexpressed inflammatory chemokine receptors. These data have important implications for our understanding of the roles for D6 in regulating inflammation and for our understanding of the control of spatial positioning of leukocytes at inflamed sites.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670187      PMCID: PMC4821389          DOI: 10.4049/jimmunol.1201429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.

Authors:  B Johnston; A R Burns; M Suematsu; T B Issekutz; R C Woodman; P Kubes
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  BX471: a CCR1 antagonist with anti-inflammatory activity in man.

Authors:  Richard Horuk
Journal:  Mini Rev Med Chem       Date:  2005-09       Impact factor: 3.862

3.  Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

Authors:  Yeny Martinez de la Torre; Chiara Buracchi; Elena M Borroni; Jana Dupor; Raffaella Bonecchi; Manuela Nebuloni; Fabio Pasqualini; Andrea Doni; Eleonora Lauri; Chiara Agostinis; Roberta Bulla; Donald N Cook; Bodduluri Haribabu; Pierluigi Meroni; Daniel Rukavina; Luca Vago; Francesco Tedesco; Annunciata Vecchi; Sergio A Lira; Massimo Locati; Alberto Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

4.  Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients.

Authors:  Judith Madigan; Dilys J Freeman; Fiona Menzies; Steve Forrow; Scott M Nelson; Anne Young; Andrew Sharkey; Ashley Moffett; Gerard J Graham; Ian A Greer; Antal Rot; Robert J B Nibbs
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

5.  Novel chemokine responsiveness and mobilization of neutrophils during sepsis.

Authors:  Cecilia L Speyer; Hongwei Gao; Nicholas J Rancilio; Thomas A Neff; Gary B Huffnagle; J Vidya Sarma; Peter A Ward
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 6.  Neutrophilic dermatoses.

Authors:  Jeffrey P Callen
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

7.  Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.

Authors:  Raffaella Bonecchi; Massimo Locati; Emanuela Galliera; Marisa Vulcano; Marina Sironi; Anna M Fra; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Bodduluri Haribabu; Jo Van Damme; Alberto Mantovani
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

8.  The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

Authors:  Robert J B Nibbs; Derek S Gilchrist; Vicky King; Antonio Ferra; Steve Forrow; Keith D Hunter; Gerard J Graham
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis.

Authors:  Veronica Codullo; Helen M Baldwin; Mark D Singh; Alasdair R Fraser; Catherine Wilson; Ashley Gilmour; Axel J Hueber; Claudia Bonino; Iain B McInnes; Carlomaurizio Montecucco; Gerard J Graham
Journal:  Ann Rheum Dis       Date:  2011-02-01       Impact factor: 19.103

10.  Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice.

Authors:  Chris A H Hansell; Chris Schiering; Ross Kinstrie; Laura Ford; Yvonne Bordon; Iain B McInnes; Carl S Goodyear; Robert J B Nibbs
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

View more
  13 in total

Review 1.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

Review 2.  T Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-Positioning.

Authors:  Alison Gaylo; Dillon C Schrock; Ninoshka R J Fernandes; Deborah J Fowell
Journal:  Front Immunol       Date:  2016-10-14       Impact factor: 7.561

3.  The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.

Authors:  Thomas M Woodcock; Tony Frugier; Tan Thanh Nguyen; Bridgette Deanne Semple; Nicole Bye; Matteo Massara; Benedetta Savino; Roberta Besio; Cristina Sobacchi; Massimo Locati; Maria Cristina Morganti-Kossmann
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

4.  CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses.

Authors:  Douglas P Dyer; Kenneth Pallas; Laura Medina-Ruiz; Fabian Schuette; Gillian J Wilson; Gerard J Graham
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

5.  ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity.

Authors:  Matteo Massara; Ornella Bonavita; Benedetta Savino; Nicoletta Caronni; Valeria Mollica Poeta; Marina Sironi; Elisa Setten; Camilla Recordati; Laura Crisafulli; Francesca Ficara; Alberto Mantovani; Massimo Locati; Raffaella Bonecchi
Journal:  Nat Commun       Date:  2018-02-14       Impact factor: 14.919

Review 6.  Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.

Authors:  Daiane Boff; Helena Crijns; Mauro M Teixeira; Flavio A Amaral; Paul Proost
Journal:  Int J Mol Sci       Date:  2018-02-05       Impact factor: 5.923

7.  Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.

Authors:  Raffaella Bonecchi; Cecilia Garlanda; Alberto Mantovani; Federica Riva
Journal:  Cytokine       Date:  2016-08-04       Impact factor: 3.861

Review 8.  Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response.

Authors:  Raffaella Bonecchi; Gerard J Graham
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

9.  MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2.

Authors:  Kave Shams; Mariola Kurowska-Stolarska; Fabian Schütte; A David Burden; Clive S McKimmie; Gerard J Graham
Journal:  J Biol Chem       Date:  2017-12-26       Impact factor: 5.157

10.  The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.

Authors:  Kay D Hewit; Alasdair Fraser; Robert J B Nibbs; Gerard J Graham
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.